Bronchiolitis Obliterans Syndrome Clinical Trial
Official title:
Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children
In this study, we will study 129Xe-MRI and LCI as tools for diagnosis of BOS in pediatric patients who have received Hematopoietic Stem Cell Transplantation (HSCT) and have been identified as eligible for this study. Participants will be required to have vital signs collected, complete breathing tests and complete an MRI. The MRI will require participants to perform breath holds in the MRI scanner with xenon gas while being coached by a research assistant.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01807975 -
Forced Oscillation Versus Spirometry in Diagnosing Post Pulmonary Transplant Bronchiolitis Obliterans Syndrome
|
N/A | |
| Completed |
NCT01009619 -
Azithromycin in Bronchiolitis Obliterans Syndrome
|
Phase 4 | |
| Recruiting |
NCT05922761 -
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
|
Phase 2 | |
| Recruiting |
NCT05250037 -
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
|
||
| Enrolling by invitation |
NCT04039347 -
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
|
Phase 3 | |
| Recruiting |
NCT05413356 -
Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
|
Phase 2 | |
| Recruiting |
NCT00774449 -
Characterization of Bronchiolitis-obliterans Syndrome (BOS) Following Lung Transplantation
|
N/A | |
| Terminated |
NCT03978637 -
Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation
|
Phase 1/Phase 2 | |
| Completed |
NCT02316392 -
Imaging and Understanding BOS in Lung Transplantation
|
||
| Completed |
NCT00528853 -
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
|
N/A | |
| Recruiting |
NCT06018766 -
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
|
Phase 2 | |
| Recruiting |
NCT02669251 -
Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
|
Phase 1/Phase 2 | |
| Completed |
NCT02863835 -
Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients
|
N/A | |
| Recruiting |
NCT03072849 -
Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation
|
N/A |